Evaluation of [13N]- Ammonia- and [18F]-FDG-PET/cMRI for cardiac sarcoidosis

Go Back to All Clinical Trials

Evaluation of [13N]- Ammonia- and [18F]-FDG-PET/cMRI for cardiac sarcoidosis

Brief description of study

Evaluate combined [13N]- Ammonia- and [18F]-FDG-PET/cardiac MRI for improved diagnosis of cardiac sarcoidosis and to assess for biomarkers associated with cardiac sarcoidosis.

Clinical Study Identifier: s18-00729

Principal Investigator: Kent P Friedman.

Other Investigators: Lawrence Phillips, Robert M Donnino, Leon Axel.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies